Microsoft used inspectable agents to identify viruses for phage therapy

Microsoft researchers recently detailed a new approach for using AI agents to accelerate the discovery of phages. Phages are viruses that naturally kill bacteria, and they offer a potential alternative to traditional antibiotics for fighting resistant infections.

Finding the right virus for a specific infection is a complex task. It usually involves sorting through massive amounts of biological data to identify candidates that match the target bacteria.

To simplify this, the team built inspectable agents. These are AI systems designed to perform research tasks while allowing human experts to monitor and verify every step of their reasoning.

These agents manage bioinformatics workflows, which are sequences of computational steps used to analyze genetic information. By automating these processes, scientists can quickly screen vast libraries of viruses.

What makes these agents useful is their transparency. The system provides a clear record of its decisions, so researchers can understand exactly how a specific candidate was chosen.

Could this automated process reduce the time it takes to develop effective new medical treatments for resistant bacteria?

It is important to note that this development is currently a workflow research project. It does not replace clinical trials, and the source does not detail specific medical outcomes or patients treated.